CE005 / Cello Therap - LARVOL DELTA

Epidemiology, risk factors and outcomes of Clostridioides difficile infection in a UK district general hospital: a retrospective cohort study. (PubMed, Infect Prev Pract) - "Relapse (9%) and recurrence (4%) occurred among those treated with oral vancomycin, whereas no relapse or recurrence was observed among patients who received fidaxomicin monotherapy...Four ribotypes, CE002, CE005, CE015 and CE020, were most frequent (each N = 11); CE001 accounted for seven cases, and 12.9% were untyped...No further episodes were observed among patients who received fidaxomicin monotherapy in this cohort. Ribotype patterns revealed predominance of non-hypervirulent strains, supporting strengthened stewardship and routine ribotype-informed surveillance."

Journal • Retrospective data • Gastroenterology • Gastrointestinal Disorder • Infectious Disease • Oncology • Pediatrics